Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02485522 · ClinicalTrials.gov registry record
Diet and Stool Metabolites in Fecal Incontinence
A clinical trial of Fecal Incontinence, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT02485522: Completed study of Fecal Incontinence, sponsored by University of Pennsylvania.
NCT02485522 is a study of Fecal Incontinence that has completed, run by University of Pennsylvania. The registered enrollment target is 28 participants, below the 334-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02485522, a study of Fecal Incontinence, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Fecal Incontinence (FI) is a debilitating and common condition with a prevalence ranging from 7-15% in community dwelling women. FI has an immense impact on quality of life and is associated with increased care giver burden, increased rates of institutionalization, and significant cost burden in older women. Traditionally believed to be primarily caused by child birth injury, recent studies show that the typical age of onset of FI is age 40 which is remote from child birth. Treatment options for FI are limited because the mechanism underlying FI in older women are poorly understood. The overriding goal of this project is to investigate the relationship between diet, stool metabolites and fecal incontinence.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-06 |
What the finished NCT02485522 record still lists
NCT02485522 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 334-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Fecal Incontinence appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT02485522 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02485522 about?
NCT02485522 is a clinical study titled "Diet and Stool Metabolites in Fecal Incontinence". Fecal Incontinence (FI) is a debilitating and common condition with a prevalence ranging from 7-15% in community dwelling women. FI has an immense impact on quality of life and is associated with increased care giver burden, increased rates of institutionalization, and significant cost burden in old...
What is the current status of trial NCT02485522?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2015-07. Estimated completion is 2017-06.
What conditions does trial NCT02485522 study?
This clinical trial studies the following conditions: Fecal Incontinence.
What interventions are being tested in trial NCT02485522?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02485522?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02485522 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fecal Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02485522's enrollment target sits among peer trials
28 17th of 22 higher than 6 of 22 other Fecal Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fecal Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Mechanisms of Improving Fecal Continence Muscles Motor Function
RECRUITING · NA
-
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
RECRUITING · NA
-
Autologous Muscle Fiber Fragment Injections
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia